UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                -----------------

                                    FORM 8-K

                                 CURRENT REPORT
                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

Date of report (Date of earliest event reported): March 1, 2006

                                   ARGAN, INC.
             (Exact Name of Registrant as Specified in its Charter)

         Delaware                         001-31756               13-1947195
(State or Other Jurisdiction             (Commission            (IRS Employer
      of Incorporation)                  File Number)        Identification No.)

  One Church Street, Suite 302, Rockville, MD                   20850
     (Address of Principal Executive Offices)                 (Zip Code)

Registrant's telephone number, including area code: (301) 315-0027

                                 Not Applicable
          (Former Name or Former Address, if Changed Since Last Report)

      Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

|_|   Written communications pursuant to Rule 425 under the Securities Act (17
      CFR 230.425)

|_|   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)

|_|   Pre-commencement communications pursuant to Rule 14d-2(b) under the
      Exchange Act (17 CFR 240.14d-2(b))

|_|   Pre-commencement communications pursuant to Rule 13e-4(c) under the
      Exchange Act (17 CFR 240.13e-4(c))

<PAGE>

Item 1.01.  Entry into a Material Definitive Agreement.

      On March 1, 2006, Vitarich Laboratories, Inc., a Delaware corporation and
a wholly-owned subsidiary of the Registrant ("Vitarich"), entered into a lease
agreement (the "First Lease") for the lease of real property from Kevin J.
Thomas. A complete copy of the First Lease is filed as Exhibit 10.1 to this Form
8-K and is incorporated herein by reference. The First Lease is for certain real
property located at 4327 Arnold Avenue in Naples, Florida, consisting of a 7,000
square foot building and all fixtures attached thereto. The same real property
was the subject of a previous lease between Mr. Thomas and the Registrant. The
base rent under the First Lease is $66,000.00 per annum (the "First Lease
Rent"), which Vitarich believes to be market for the area, and the lease is for
a term of five years ending in 2011, unless sooner terminated or extended in
accordance with the terms of the First Lease. The First Lease Rent is payable in
equal monthly installments of $5,500.00. This disclosure regarding the First
Lease is being made because it involves a related party arrangement between a
subsidiary of the Registrant and Mr. Thomas, who owns 43.99% of the Registrant's
common stock.

      On March 1, 2006, Vitarich entered into a second lease agreement (the
"Second Lease") for the lease real property from Kevin J. Thomas. A complete
copy of the Second Lease is filed as Exhibit 10.2 to this Form 8-K and is
incorporated herein by reference. The Second Lease is for certain real property
located at 4206 Arnold Avenue in Naples, Florida, consisting of a 14,712 square
foot building and all fixtures attached thereto. The same real property was the
subject of a previous lease between Mr. Thomas and the Registrant. The base rent
under the Second Lease is $150,000.00 per annum (the "Second Lease Rent"), which
Vitarich believes to be market for the area, and the lease is for a term of five
years ending in 2011, unless sooner terminated or extended in accordance with
the terms of the Second Lease. The Second Lease Rent is payable in equal monthly
installments of $12,500.00. This disclosure regarding the Second Lease is being
made because it involves a related party arrangement between a subsidiary of the
Registrant and Mr. Thomas, who owns 43.99% of the Registrant's common stock.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

    Exhibit No.         Description
    -----------         -----------
    10.1                Lease Agreement between Kevin J. Thomas and Vitarich
                        Laboratories, Inc., dated March 1, 2006

    10.2                Lease Agreement between Kevin J. Thomas and Vitarich
                        Laboratories, Inc., dated March 1, 2006

<PAGE>

                                   SIGNATURES

         Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                               ARGAN, INC.

Date: March 6, 2006                            By: /s/ Rainer Bosselmann
                                                   -----------------------------
                                                     Rainer Bosselmann
                                                     Chairman of the Board and
                                                     Chief Executive Officer

<PAGE>

                                  EXHIBIT INDEX

    Exhibit No.         Description
    -----------         -----------
    10.1                Lease Agreement between Kevin J. Thomas and Vitarich
                        Laboratories, Inc., dated March 1, 2006

    10.2                Lease Agreement between Kevin J. Thomas and Vitarich
                        Laboratories, Inc., dated March 1, 2006
{"company-data": {"conformed-name": "ARGAN INC", "cik": "0000100591", "assigned-sic": "2833", "irs-number": "131947195", "state-of-incorporation": "DE", "fiscal-year-end": "0131"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-31756", "film-number": "06667806"}, "business-address": {"street1": "ONE CHURCH STREET", "street2": "SUITE 302", "city": "ROCKVILLE", "state": "MD", "zip": "20850", "phone": "301 315-0027"}, "mail-address": {"street1": "ONE CHURCH STREET", "street2": "SUITE 302", "city": "ROCKVILLE", "state": "MD", "zip": "20850"}, "former-company": [{"former-conformed-name": "PUROFLOW INC", "date-changed": "19920703"}, {"former-conformed-name": "ULTRA DYNAMICS CORP", "date-changed": "19830522"}]}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                -----------------

                                    FORM 8-K

                                 CURRENT REPORT
                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

Date of report (Date of earliest event reported): March 1, 2006

                                   ARGAN, INC.
             (Exact Name of Registrant as Specified in its Charter)

         Delaware                         001-31756               13-1947195
(State or Other Jurisdiction             (Commission            (IRS Employer
      of Incorporation)                  File Number)        Identification No.)

  One Church Street, Suite 302, Rockville, MD                   20850
     (Address of Principal Executive Offices)                 (Zip Code)

Registrant's telephone number, including area code: (301) 315-0027

                                 Not Applicable
          (Former Name or Former Address, if Changed Since Last Report)

      Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

|_|   Written communications pursuant to Rule 425 under the Securities Act (17
      CFR 230.425)

|_|   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)

|_|   Pre-commencement communications pursuant to Rule 14d-2(b) under the
      Exchange Act (17 CFR 240.14d-2(b))

|_|   Pre-commencement communications pursuant to Rule 13e-4(c) under the
      Exchange Act (17 CFR 240.13e-4(c))
Item 1.01.  Entry into a Material Definitive Agreement.

      On March 1, 2006, Vitarich Laboratories, Inc., a Delaware corporation and
a wholly-owned subsidiary of the Registrant ("Vitarich"), entered into a lease
agreement (the "First Lease") for the lease of real property from Kevin J.
Thomas. A complete copy of the First Lease is filed as Exhibit 10.1 to this Form
8-K and is incorporated herein by reference. The First Lease is for certain real
property located at 4327 Arnold Avenue in Naples, Florida, consisting of a 7,000
square foot building and all fixtures attached thereto. The same real property
was the subject of a previous lease between Mr. Thomas and the Registrant. The
base rent under the First Lease is $66,000.00 per annum (the "First Lease
Rent"), which Vitarich believes to be market for the area, and the lease is for
a term of five years ending in 2011, unless sooner terminated or extended in
accordance with the terms of the First Lease. The First Lease Rent is payable in
equal monthly installments of $5,500.00. This disclosure regarding the First
Lease is being made because it involves a related party arrangement between a
subsidiary of the Registrant and Mr. Thomas, who owns 43.99% of the Registrant's
common stock.

      On March 1, 2006, Vitarich entered into a second lease agreement (the
"Second Lease") for the lease real property from Kevin J. Thomas. A complete
copy of the Second Lease is filed as Exhibit 10.2 to this Form 8-K and is
incorporated herein by reference. The Second Lease is for certain real property
located at 4206 Arnold Avenue in Naples, Florida, consisting of a 14,712 square
foot building and all fixtures attached thereto. The same real property was the
subject of a previous lease between Mr. Thomas and the Registrant. The base rent
under the Second Lease is $150,000.00 per annum (the "Second Lease Rent"), which
Vitarich believes to be market for the area, and the lease is for a term of five
years ending in 2011, unless sooner terminated or extended in accordance with
the terms of the Second Lease. The Second Lease Rent is payable in equal monthly
installments of $12,500.00. This disclosure regarding the Second Lease is being
made because it involves a related party arrangement between a subsidiary of the
Registrant and Mr. Thomas, who owns 43.99% of the Registrant's common stock.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

    Exhibit No.         Description
    -----------         -----------
    10.1                Lease Agreement between Kevin J. Thomas and Vitarich
                        Laboratories, Inc., dated March 1, 2006

    10.2                Lease Agreement between Kevin J. Thomas and Vitarich
                        Laboratories, Inc., dated March 1, 2006
SIGNATURES

         Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                               ARGAN, INC.

Date: March 6, 2006                            By: /s/ Rainer Bosselmann
                                                   -----------------------------
                                                     Rainer Bosselmann
                                                     Chairman of the Board and
                                                     Chief Executive Officer
EXHIBIT INDEX

    Exhibit No.         Description
    -----------         -----------
    10.1                Lease Agreement between Kevin J. Thomas and Vitarich
                        Laboratories, Inc., dated March 1, 2006

    10.2                Lease Agreement between Kevin J. Thomas and Vitarich
                        Laboratories, Inc., dated March 1, 2006